Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.108.179622PMID 19359665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dipyridamole enhances ischaemia‐induced reactive hyperaemia by increased adenosine receptor stimulation

  2008cited by this paper
• Simvastatin with or without ezetimibe in familial hypercholesterolemia.

  2008cited by this paper
• Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.

  2008cited by this paper
• Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.

  2008cited by this paper
• Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia–Reperfusion Injury in the Rat

  2008cited by this paper
• Diannexin, a Novel Annexin V Homodimer, Protects Rat Liver Transplants Against Cold Ischemia‐Reperfusion Injury

  2007cited by this paper
• Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.

  2007cited by this paper
• Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.

  2007cited by this paper
• Statins: Multiple Mechanisms of Action in the Ischemic Brain

  2007cited by this paper
• Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.

  2007cited by this paper
• Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

  2007cited by this paper
• CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation

  2006cited by this paper
• Coffee, CYP1A2 genotype, and risk of myocardial infarction.

  2006cited by this paper
• Caffeine prevents protection in two human models of ischemic preconditioning.

  2006cited by this paper
• In vivo evidence against a role for adenosine in the exercise pressor reflex in humans.

  2005cited by this paper
• Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans

  2005cited by this paper
• Oral therapy with dipyridamole limits ischemia‐reperfusion injury in humans

  2005cited by this paper
• Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft Surgery

  2004cited by this paper
• Optimal Windows of Statin Use for Immediate Infarct Limitation: 5′-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase

  2004cited by this paper
• Glyburide Inhibits Dipyridamole‐induced Forearm Vasodilation but not Adenosine‐induced Forearm Vasodilation

  2004cited by this paper
• Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.

  2004cited by this paper
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Lovastatin Enhances Ecto-5′-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases

  2002cited by this paper
• Diadenosine pentaphosphate vasodilates the forearm vascular bed: Inhibition by theophylline and augmentation by dipyridamole

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

  2001cited by this paper
• Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction.

  2000cited by this paper
• Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis

  2000cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction.

  1999cited by this paper
• Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.

  1999cited by this paper
• Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

  1999cited by this paper
• Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient.

  1999cited by this paper
• Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart.

  1993cited by this paper
• Protection Against Infarction Afforded by Preconditioning is Mediated by A1 Adenosine Receptors in Rabbit Heart

  1991cited by this paper
• Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

  1986cited by this paper
• The cardiovascular effects of regular and decaffeinated coffee.

  1985cited by this paper

• Physicochemical Characteristics of Cardiological Drugs and Practical Recommendations for Intravenous Administration: A Systematic Review

  2025cites this paper
• Caffeine Drug Interactions and its Clinical Implication After Acute Coronary Syndrome: A Literature Review

  2023cites this paper
• Therapeutic Options for Migraines in the Microsurgical Patient: A Scoping Review

  2023cites this paper
• Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era

  2021cites this paper
• Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic.

  2021cites this paper
• Radionuclide imaging of apoptosis for clinical application

  2021cites this paper
• The integrated physiology of glucose homeostasis: regulation by extracellular and intracellular nucleotide sensors

  2020cites this paper
• Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs

  2020cites this paper
• Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia‐reperfusion injury: A prospective case‐control study

  2019cites this paper
• Accurate measurement of endogenous adenosine in human blood

  2018cites this paper
• Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1)

  2018cites this paper
• The of Ectonucleotidases ammation

  2016cites this paper
• Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration

  2016cites this paper
• Targeting the adenosine system to limit ischemia-reperfusion injury : translational research in humans

  2016cites this paper
• Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery

  2016cites this paper
• Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo

  2015cites this paper
• The Effect of Eplerenone on Adenosine Formation in Humans In Vivo: A Double-Blinded Randomised Controlled Study

  2014cites this paper
• The immunomodulatory actions of adenosine during systemic inflammation

  2014cites this paper
• Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion

  2014cites this paper
• Extracellular Adenosine-Mediated Modulation of Regulatory T Cells

  2014cites this paper
• Impact of Metformin on Endothelial Ischemia-Reperfusion Injury in Humans In Vivo: A Prospective Randomized Open, Blinded-Endpoint Study

  2014cites this paper
• Pharmacological approaches to coronary microvascular dysfunction.

  2014cites this paper
• Defining the Role of High-Dose Statins in PCI

  2013cites this paper
• In vivo imaging of retinal ganglion cell apoptosis.

  2013cites this paper
• Therapy against ischemic injury.

  2013cites this paper
• Initiation Of Statin Therapy - Lack Of Effect On MR Spectroscopy And Cerebral Perfusion

  2013cites this paper
• Assessment of ischaemia and reperfusion injury

  2013cites this paper
• The Outsiders: Emerging Roles of Ectonucleotidases in Inflammation

  2012cites this paper
• Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo.

  2012cites this paper
• Targeting adenosine receptors in the development of cardiovascular therapeutics

  2012cites this paper
• How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo

  2012cites this paper
• Short-term Statin Treatment Does Not Prevent Ischemia and Reperfusion-induced Endothelial Dysfunction in Humans

  2012cites this paper
• Novel protective approaches in ischemia - reperfusion injury. In vivo studies in animals and humans

  2012cites this paper
• Angiotensin II Type 1 Receptor Blockade Does Not Enhance Apoptotic Cell Death During Ischemia and Reperfusion in Humans In Vivo

  2011cites this paper
• Modulators of nucleoside metabolism in the therapy of brain diseases.

  2011cites this paper
• Xanthine derivatives in the heart: blessed or cursed?

  2011cites this paper
• The cardiovascular effects of methylxanthines.

  2011cites this paper
• Homing‐associated molecules CD73 and VAP‐1 as targets to prevent harmful inflammations and cancer spread

  2011cites this paper
• Upregulation of Ecto-5′-Nucleotidase by Rosuvastatin Increases the Vasodilator Response to Ischemia

  2010cites this paper
• Prevention of Peri-procedural Myocardial Injury Using a Single High Loading Dose of Rosuvastatin

  2010cites this paper
• The Anti-Ischemic and Anti-Anginal Properties of Statins

  2010cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper